X
27Mar

Update — Antitrust and COVID-19

- US Agencies Encourage COVID-19-Related Collaboration - Practical Tips for Information Sharing & Document Creation - Possible Delays to US Merger Approvals The ongoing COVID-19 outbreak has, at least temporarily, reshaped the way that many...
By: Shearman & Sterling LLP
Source Url: https://www.jdsupra.com/legalnews/update-antitrust-and-covid-19-84473/

Related

The Supreme Court Asks DOJ For Input On The Scope Of Title VII

Recently, the United States Supreme Court invited the U.S. Solicitor General of the Department of Ju...

Read More >

Breaking fiduciary ties in an asset purchase agreement

Does a corporate director of a vendor corporation owe independent fiduciary duties to a purchasing c...

Read More >

District of Delaware Grants Motions for Summary Judgment in Three Risperdal Gynecomastia Cases

In a trio of recent decisions arising out of cases alleging that an antipsychotic medication, Risper...

Read More >

SBA Change in Ownership Approval Guidance

SBA Releases Guidance Addressing Corporate Mergers and Acquisitions in the Context of Paycheck Prote...

Read More >

Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices

On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharm...

Read More >

New York Prescription Drug Formulary Reform Implementation

New York’s 2017-2018 Executive Budget, enacted effective April 10, 2017, included significant refor...

Read More >